Korean Market
OWNR
DaehanPharmaceutical
★

Largest Shareholder Lee Yun-woo Increases Stake from 38.67% to 39.67% via Open Market Purchases, Signaling Strengthened Control

 
OWNR
DaehanPharmaceutical
★

Chairman Lee Yun-woo boosts stake to 24.67% via open-market purchase... Limited real impact due to small volume

 
OWNR
DaehanPharmaceutical
★

Chairman Lee Yun-woo Increases Stake to 24.66% with Open Market Purchase of 800 Shares

 
PERI
DaehanPharmaceutical
★

Daihan Pharm 2026 Q1 Operating Profit Down, Dividend Up